ArticleMolecular therapy. Methods & clinical development2021

Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy.

Hiroaki Mashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.